China Universal Asset Management Co., Ltd. Gilead Sciences, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$1.05 Billion
Q1 2025

A detailed history of China Universal Asset Management Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 171,470 shares of GILD stock, worth $18.9 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

171,470

Previous 218,445 21.5%

Holding current value

$18.9 Million

Previous $20.2 Million 4.78%

% of portfolio

1.84%

Previous 1.96%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$89.14 - $117.41 $4.19 Million - $5.52 Million	-46,975 Reduced 21.5%	171,470 $19.2 Million
Q4 2024 Jan 23, 2025	BUY	$83.95 - $97.9 $153,964 - $179,548	1,834 Added 0.85%	218,445 $20.2 Million
Q3 2024 Oct 25, 2024	BUY	$66.59 - $83.99 $4.89 Million - $6.17 Million	73,443 Added 51.3%	216,611 $18.2 Million
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $4.5 Million - $5.19 Million	-71,260 Reduced 33.23%	143,168 $9.82 Million
Q1 2024 Apr 29, 2024	BUY	$71.58 - $87.29 $7.41 Million - $9.03 Million	103,466 Added 93.24%	214,428 $15.7 Million
Q4 2023 May 21, 2024	SELL	$73.27 - $83.09 $7.58 Million - $8.6 Million	-103,466 Reduced 48.25%	110,962 $8.99 Million
Q4 2023 Jan 23, 2024	BUY	$73.27 - $83.09 $5.77 Million - $6.54 Million	78,723 Added 244.19%	110,962 $8.99 Million
Q3 2023 May 21, 2024	BUY	$73.94 - $80.67 $1.21 Million - $1.32 Million	16,305 Added 102.33%	32,239 $2.42 Million
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $1.21 Million - $1.32 Million	16,305 Added 102.33%	32,239 $2.42 Million
Q2 2023 May 21, 2024	BUY	$76.01 - $86.7 $107,250 - $122,333	1,411 Added 9.72%	15,934 $1.23 Million
Q2 2023 Jul 27, 2023	BUY	$76.01 - $86.7 $107,250 - $122,333	1,411 Added 9.72%	15,934 $1.23 Million
Q1 2023 May 21, 2024	BUY	$77.31 - $88.08 $342,792 - $390,546	4,434 Added 43.95%	14,523 $1.2 Million
Q1 2023 Apr 27, 2023	BUY	$77.31 - $88.08 $342,792 - $390,546	4,434 Added 43.95%	14,523 $1.21 Million
Q4 2022 May 21, 2024	SELL	$62.32 - $89.47 $12.7 Million - $18.3 Million	-204,339 Reduced 95.29%	10,089 $866,000
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $100,709 - $144,583	-1,616 Reduced 13.81%	10,089 $866,000
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $696,915 - $796,057	11,705 New	11,705 $722,000

Others Institutions Holding GILD

# of Institutions

2,288

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $138B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Gilead Sciences, Inc. Transaction History